Menorrhagia
Conditions
Interventions
Trade Name: Mirena IUS
Product Name: Mirena IUS
Pharmaceutical Form: Intrauterine delivery system
Sponsors
Hull and East Yorkshire Acute Hospitals NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All women who have chosen and who have been fitted with a Mirena IUS as a way of controlling their heavy periods and who have asked to be included in the study. Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 200 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range 0
Exclusion criteria
Exclusion criteria: Any woman unwilling to attend for blood samples and vaginal ultrasound scans.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: We wish to establish whether women who require treatment for their heavy periods respond as favourably to the use of a Mirena IUS whether they have fibroids or not.;Secondary Objective: We wish to establish whether a Mirena IUS causes a reduction in the size of uterine fibroids;Primary end point(s): Bloodloss as determined by pictorial bloodloss assessment charts (PBAC) | — |
Countries
United Kingdom
Outcome results
None listed